Bank of America’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-127,300
Closed -$7.24M 7993
2022
Q4
$7.24M Buy
+127,300
New +$6.52M ﹤0.01% 3002
2018
Q1
Sell
-3,300
Closed -$67K 7189
2017
Q4
$67K Buy
+3,300
New +$60.7K ﹤0.01% 5931
2017
Q2
Sell
-15,000
Closed -$194K 7028
2017
Q1
$194K Buy
+15,000
New +$190K ﹤0.01% 5328
2015
Q1
Sell
-5,000
Closed -$48K 7258
2014
Q4
$48K Sell
5,000
-2,100
-30% -$18.7K ﹤0.01% 6373
2014
Q3
$65K Buy
7,100
+4,700
+196% +$44.8K ﹤0.01% 6333
2014
Q2
$24K Hold
2,400
﹤0.01% 7083
2014
Q1
$30K Sell
2,400
-1,000
-29% -$14.8K ﹤0.01% 6711
2013
Q4
$51K Buy
+3,400
New +$43.7K ﹤0.01% 6540

Other funds holding HALO

Bank of America's HALO Position: Q1 2026 in Review

Bank of America increased its Halozyme (HALO) stake by 6.6% in Q1 2026, buying an estimated $12.6M and bringing the position to 2,913,109 shares worth $188M. The position accounts for 0.01% of the portfolio, ranked #770.

Bank of America first reported a position in HALO in Q2 2013 and has held it in 52 quarters since. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Bank of America held 2,913,109 shares of Halozyme worth $188M as of Q1 2026.
  • Bank of America bought 179,277 Halozyme shares in Q1 2026, an estimated $12.6M.
  • Halozyme made up 0.01% of Bank of America's portfolio in Q1 2026, its #770 holding.
  • Bank of America first reported a position in Halozyme in Q2 2013 and has held it in 52 quarters since.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.